J&J’s One-Shot Vaccine Shows 66% Efficacy, But Company Says There’s More To It
Prevention Of Severe Disease Consistent Across Geographies
The drug maker played up the 85% prevention of severe disease and 100% prevention of hospitalization and death despite lower overall efficacy relative to mRNA vaccines.
